experts respond to the fda’s approval of aducanumab | livetalk | being patient
Published 3 years ago • 2.4K plays • Length 35:03Download video MP4
Download video MP3
Similar videos
-
2:23
experts responds to fda approval of aducanumab | being patient
-
33:06
the implications of fda's decision on aducanumab | braintalk | being patient
-
27:33
perspective of the first patient to receive aduhelm in clinical practice | livetalk | being patient
-
1:19
what is aducanumab and how does it work | new biogen alzheimer's drug 101
-
7:19
new alzheimer's drug aducanumab approved in the us is dividing doctors and patients | 7.30
-
26:16
what does an alzheimer's drug relaunch mean for a cure? | brain talks | being patient
-
50:40
navigating life after an alzheimer's diagnosis as a retired physician | livetalk | being patient
-
59:52
a closer look at the infectious theory of alzheimer's | livetalk | being patient
-
4:03
celebration & controversy after fda approves drug to treat early-stage alzheimer’s
-
33:50
a deep dive into the investigational alzheimer’s drug donanemab | livetalk | being patient
-
20:52
clinical trial participant 'biogen's aducanumab was working' | patient perspectives | being patient
-
5:59
aduhelm is fda approved for alzheimer's, but does it work?
-
9:14
discussing aducanumab with alzheimer's disease experts | healthy living with mci special segment
-
0:59
the fda has approved aducanumab (aduhelm™). now what?
-
42:06
caregiver strategies for managing the symptoms of dementia | livetalk | being patient
-
32:51
where’s our alzheimer's cure? an inside look at what’s taking so long | livetalk | being patient
-
39:20
finding a new path in life with alzheimer’s | livetalk | being patient
-
55:24
understanding the aducanumab (aduhelm) approval in the us
-
5:55
controversy around fda’s approval of biogen alzheimer’s drug, aducanumab